Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

NCT00037557 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia B

Interventions

DRUG: BeneFIX

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer